{"entity":{"type":"insider","cik":"0001780080","url":"/insider/0001780080","json_url":"/insider/0001780080.json","name":"Clements Ian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2019-09-10","last":"2021-11-29","span_basis":"filed_date"},"name_variants":[{"name":"Clements Ian","source":"filing","n_filings":5,"first_seen":"2019-09-10","last_seen":"2021-11-29"}],"transactions":[{"id":5056694,"accession":"0001209191-21-067068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-067068","line_url":"/filing/0001209191-21-067068#line-2","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780080","owner_name":"Clements Ian","owner_display_name":"Clements Ian","owner_url":"/insider/0001780080","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750.0,"shares_display":"750","price_per_share":13.9,"price_display":"13.90","price_state":"stated","total_value":10425.0,"total_display":"10,425.00","total_whole":"10,425","shares_owned_after":18561.0,"shares_owned_after_display":"18,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-29","scope":"insider"},{"id":5056690,"accession":"0001209191-21-067068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-067068","line_url":"/filing/0001209191-21-067068#line-1","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780080","owner_name":"Clements Ian","owner_display_name":"Clements Ian","owner_url":"/insider/0001780080","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":14.4,"price_display":"14.40","price_state":"stated","total_value":10080.0,"total_display":"10,080.00","total_whole":"10,080","shares_owned_after":17811.0,"shares_owned_after_display":"17,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-29","scope":"insider"},{"id":5113007,"accession":"0001209191-21-058607","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-058607","line_url":"/filing/0001209191-21-058607#line-2","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780080","owner_name":"Clements Ian","owner_display_name":"Clements Ian","owner_url":"/insider/0001780080","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1574.0,"shares_display":"1,574","price_per_share":19.256,"price_display":"19.26","price_state":"stated","total_value":30308.944,"total_display":"30,308.94","total_whole":"30,309","shares_owned_after":16653.0,"shares_owned_after_display":"16,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-01","scope":"insider"},{"id":9271414,"accession":"0001209191-21-018770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-018770","line_url":"/filing/0001209191-21-018770#line-1","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780080","owner_name":"Clements Ian","owner_display_name":"Clements Ian","owner_url":"/insider/0001780080","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1592.0,"shares_display":"1,592","price_per_share":18.65,"price_display":"18.65","price_state":"stated","total_value":29690.8,"total_display":"29,690.80","total_whole":"29,691","shares_owned_after":7871.0,"shares_owned_after_display":"7,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2021-03-08","scope":"insider"},{"id":3325855,"accession":"0001209191-20-065167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-065167","line_url":"/filing/0001209191-20-065167","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780080","owner_name":"Clements Ian","owner_display_name":"Clements Ian","owner_url":"/insider/0001780080","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2470.0,"shares_display":"2,470","price_per_share":18.61323886639676,"price_display":"18.61","price_state":"stated","total_value":45974.7,"total_display":"45,974.70","total_whole":"45,975","shares_owned_after":7841.0,"shares_owned_after_display":"7,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2020-12-28","scope":"insider","n_lines":2},{"id":8068580,"accession":"0001209191-19-049092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049092","line_url":"/filing/0001209191-19-049092","is_derivative":false,"issuer_cik":"0001759425","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001759425","owner_cik":"0001780080","owner_name":"Clements Ian","owner_display_name":"Clements Ian","owner_url":"/insider/0001780080","role":"Officer (SVP Finance & Communications)","role_mark":"O","role_mark_label":"Officer (SVP Finance & Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Finance & Communications","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":11.5098,"price_display":"11.51","price_state":"stated","total_value":46039.2,"total_display":"46,039.20","total_whole":"46,039","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-06","filed_date":"2019-09-10","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001759425","name":"Mirum Pharmaceuticals, Inc.","url":"/issuer/0001759425","role":"Officer (Chief Financial Officer)","n_filings":5,"first_seen":"2019-09-10","last_seen":"2021-11-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001780080","retrieved_at":"2026-08-24T04:20:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}